期刊文献+

子宫肌瘤和卵巢癌患者血清自体荧光光谱的分析 被引量:1

The analysis of auto-fluorescent spectrum of serum for Hysteromyoma or Oophoroma
原文传递
导出
摘要 目的测定子宫肌瘤和卵巢癌患者血清自体荧光光谱,探讨子宫肌瘤和卵巢癌的特征自体荧光光谱,为子宫肌瘤和卵巢癌的光谱学诊断提供理论依据。方法应用荧光分光光度计,在301nm的激发光激发下,对23例子宫肌瘤患者、17例卵巢癌患者和40例正常人的血清进行了测定,对其荧光光谱的峰位置、峰面积、峰高及主峰间的比值进行了分析。结果子宫肌瘤组在335nm附近发生了紫移(P<0.05),卵巢癌组在540nm附近明显红移(P<0.05)。子宫肌瘤组及卵巢癌组在302nm附近的峰高明显升高(P<0.05)。子宫肌瘤和卵巢癌患者的血清自体荧光光谱与正常人有显著的差异(P<0.05),子宫肌瘤和卵巢癌患者有其特征的荧光光谱。结论应用血清自体荧光光谱对子宫肌瘤和卵巢癌患者进行诊断具有重要的参考价值。 Objective Measure auto - fluorescent spectrum of serum for Hysteromyoma or oophoroma diseases, explore the characteristic spectrum of different Hysteromyoma or oophoroma diseases, in order to supply theoretical proof for spectroscopic diagno- sis for Hysteremyoma or oophoroma diseases. Methods Measure auto - fluorescent spectrum of serum for 23 cases of Hysteromyoma, ,17 cases of oophoroma and 40 normal people with wavelength 301nm by fluorospectrophotometer, then analyze fluorescent spectrum of the peak positions, areas, heights and ratio of main peak. Results Hysteromyoma group move violet shift with wavelength 335 nm. ( P 〈 0.05 ), oophorema r group move red shift ( P 〈 0.05 ) with wavelength 540 nm obviously, the peak heights of Hysteromyoma or oophoroma go up a lot with wavelength 302nm( P 〈 0.05) obviously. So there are obvious significant difference between auto - fluorescent spectrum of serum for gynecologic carcinoma and normal people, therefore, Hysteromyoma or oophoroma group has characteristic fluorescent spectrum. Conclusion It has important value that making Hysteromyoma or oophoroma people's diagnosis through measureing auto - fluorescent spectrum of serum for Hysteromyoma or oophoroma diseases .
出处 《河南预防医学杂志》 2010年第3期174-176,共3页 Henan Journal of Preventive Medicine
关键词 子宫肌瘤和卵巢癌 血清 荧光光谱 光谱分析 Hysteromyoma or oophoroma Serum Fluorescent spectrum Spectrum analysis
  • 相关文献

参考文献9

二级参考文献100

  • 1殷光中,谭纪伏,于常青,窦晓鸣.胃癌荧光光谱特性初步研究[J].中国激光医学杂志,2004,13(3):168-168. 被引量:7
  • 2孟继武,侯尚公,张新夷,徐叙瑢,西坂刚,深海隆明,大仓一郎,张新夷,徐叙瑢.肿瘤发展过程中卟啉代谢的特点及其在肿瘤诊断上的意义[J].科学通报,1995,40(12):1144-1147. 被引量:25
  • 3孟继武 侯尚公 徐叙王容 等.人胃组织匀浆的荧光.发光学报,1985,6:341-347.
  • 4深海隆明 大仓一郎 孟继武 等.癌进行に伴う血中ホルフィリンの变动[J].信学技报,1993,3:49-52.
  • 5孟继武 侯尚公 徐叙 等.癌患者血清的特异荧光研究.科学通报,1988,33:630-634.
  • 6PARAZZINI F, CHIAFFARINO F, POLVERION G, et al. Uterine fibroids risk and history of selected medical conditions linked with femal hormones [ J ]. Eur J Epidemiol, 2004,19(3) :249 -253.
  • 7HOFFMAN PJ, MILLIKEN DB, GREGG LC, et al. Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis [ J ]. Fertil Steril,2004,82 (3) :639 - 649.
  • 8MARTEL KM, KO AC, CHRISTMAN GM, et al. Apoptosis in human uterine leiomyomas [ J]. Semin Reprod Med, 2004,22(2) :91 - 103.
  • 9SABAH M, CUMMINS R, LEADER M, et al. Immunoreactivity of p53, Mdm2, p21 (WAF1/CIP1) Bcl-2, and Bax in soft tissue sarcomas : correlation with histologic grade [ J]. hppl Immuuohistochem Mol Morphol, 2007,15 ( 1 ) : 64 - 69.
  • 10KOVACS KA, LENGYEL F, KORNYEI JL, et al. Differential expression of Akt/protein kinase B, Bcl-2 and bax proteins in human leiomyoma and myometrium [ J ]. J Steroid Biochem Mol Biol, 2003,87 (4 - 5 ) : 233 - 240.

共引文献56

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部